Novel 5-HT3 receptor modulators are disclosed, in particular compounds of theformula(See formula I)These compounds are used in the treatment of various disorders, includingchemotherapy-induced nausea and vomiting, post-operative nausea and vomiting,andirritable bowel syndrome. Methods of making these compounds are also describedin thepresent invention.